Literature DB >> 23437533

[Cuban strategy for the molecular characterization of the pandemic influenza A virus (H1N1)].

Alexander Piñón Ramos1, Belsy Acosta Herrera, Odalys Valdés Ramírez, Amely Arencibia García, Clara Estela Savón Valdés, Grehete González Muñoz, Suset Isabel Oropesa Fernández, Elías Quilarte García, Guelsys González Baez, Bárbara Hernández Espinosa, Angel Goyenechea Hernández, María Guadalupe Guzmán Tirado, Alina Llop Hernández, Vivian Kourí Cardellá.   

Abstract

INTRODUCTION: In April 2009, there was identified a variant of the A/H1N1 influenza virus of swine origin, and shortly after the first pandemic in XXI century was declared.
OBJECTIVES: To establish a nucleotide sequencing strategy for the differential diagnosis of the seasonal and pandemic influenza A viruses, and to obtain as much molecular information as possible about hemagglutinin and neuraminidase genes in patients with influenza-like illnesses, in those with severe respiratory infection and in patients who died.
METHODS: Three sequencing strategies were designed and implemented, which also offered important information about the new virus in Cuba.
RESULTS: The third strategy provided the most comprehensive results such as differential diagnosis, the surveillance of the D222G/E mutation in hemagglutinin and Tamiflu-resistant H275Y viral variants. In spite of the fact that the mentioned mutations were not detected, their presence in the Cuban population can not be ignored since these strategies were not designed for this end. It is imperative to design a study to fulfill this objective.
CONCLUSIONS: The sequencing strategies in our algorithm allowed the differential diagnosis of the seasonal and the pandemic viruses, and their molecular characterization.

Entities:  

Mesh:

Year:  2011        PMID: 23437533

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  1 in total

1.  Rapid diagnosis of pandemic (H1N1) 2009 in Cuba.

Authors:  Belsy Acosta; Alexander Piñón; Odalys Valdés; Clara Savón; Amely Arencibía; Elías Guilarte; Gonzalez Grehete; Suset Oropesa; Gonzalez Guelsys; Bárbara Hernández; Angel Goyenechea; Mayra Muné; Vivian Kouri; María G Guzmán; Alina Llop
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.